23 The recent wave of state Medicaid agencies withdrawing or restricting coverage for AOMs, particularly GLP-1s, reflects a unique tension between groundbreaking clinical efficacy, rapid uptake, optional coverage, and immediate fiscal reality
Importantly, these medications carry a boxed warning about the risk of thyroid C-cell tumors and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
That means theyve undergone extensive content verification and safety testing, so you can be sure that youre getting a high-quality product
We offer nutrition counseling and, if needed, extra clinical support like IV treatments or injections
Patients transporting Wegovy without proper insulation, coolers, or temperature monitoring risk exposing the medication to heat, which is semaglutide's greatest enemy
Licensure and who signs the prescription Begin with the clinician